Literature DB >> 15319798

Uridine phosophorylase: an important enzyme in pyrimidine metabolism and fluoropyrimidine activation.

Deliang Cao1, Giuseppe Pizzorno.   

Abstract

Uridine phosphorylase (UPase) is an enzyme that can convert uridine to uracil. Upon the availability of substrates, UPase can also catalyze the formation of nucleosides from uracil or 5-fluorouracil (5-FU) and ribose-1-phosphate (Rib-1-P). UPase gene expression appears featured with the developmental regulation and strictly controlled at promoter level by oncogenes, tumor suppressor genes and cytokines. UPase activity is usually elevated in various tumor tissues, and this induction appears to confer 5-FU therapeutic advantage to cancer patients. UPase is the most important phosphorylase identified up to date in the regulation of uridine homeostasis, although thymidine phosphorylase (TPase) can utilize to a certain extent uridine as a substrate. The modulation of UPase activity by its specific inhibitors such as benzylacyclouridine or the disruption of this gene greatly affects uridine metabolism and pyrimidine nucleotide biosynthesis. UPase also plays an appreciable role in the activation of 5-FU and its prodrug 5'-deoxy-5-fluorouridine (5'DFUR)/capecitabine via anabolism of 5-FU through pyrimidine salvage pathway or the phosphorolysis of 5'DFUR into 5-FU. In this review, we discuss in detail the role of UPase in the regulation of uridine homeostasis and pyrimidine metabolism and in the activation of fluoropyrimidines. To address its potential in cancer treatment, we will also discuss the regulatory mechanisms of UPase gene expression and its induction in tumor tissues. (c) 2004 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319798     DOI: 10.1358/dot.2004.40.5.850491

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  22 in total

1.  Coordination of the transcriptome and metabolome by the circadian clock.

Authors:  Kristin L Eckel-Mahan; Vishal R Patel; Robert P Mohney; Katie S Vignola; Pierre Baldi; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

2.  Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity.

Authors:  Deliang Cao; Amy Ziemba; James McCabe; Ruilan Yan; Laxiang Wan; Bradford Kim; Michael Gach; Stuart Flynn; Giuseppe Pizzorno
Journal:  Mol Cancer Ther       Date:  2011-09-27       Impact factor: 6.261

3.  Gene expression variations in microsatellite stable and unstable colon cancer cells.

Authors:  Marjun P Duldulao; Wendy Lee; Maithao Le; Zhenbin Chen; Wenyan Li; Jinhui Wang; Harry Gao; Haiquing Li; Joseph Kim; Julio Garcia-Aguilar
Journal:  J Surg Res       Date:  2011-07-07       Impact factor: 2.192

Review 4.  Thymidine Phosphorylase in Cancer; Enemy or Friend?

Authors:  Yasir Y Elamin; Shereen Rafee; Nemer Osman; Kenneth J O Byrne; Kathy Gately
Journal:  Cancer Microenviron       Date:  2015-08-23

5.  Metabolites modulate the functional state of human uridine phosphorylase I.

Authors:  Yu-Ting Huang; Pei-Chin Yeh; Shih-Chun Lan; Pei-Fen Liu
Journal:  Protein Sci       Date:  2020-09-28       Impact factor: 6.725

6.  A novel structural mechanism for redox regulation of uridine phosphorylase 2 activity.

Authors:  Tarmo P Roosild; Samantha Castronovo; Adelbert Villoso; Amy Ziemba; Giuseppe Pizzorno
Journal:  J Struct Biol       Date:  2011-08-10       Impact factor: 2.867

7.  Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts.

Authors:  Z Q Yuan; L Nicolson; B Marchetti; E A Gault; M S Campo; L Nasir
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

8.  Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues.

Authors:  Yoichi Kobayashi; Yasuna Wada; Tatsuru Ohara; Yoshiko Okuda; Nao Suzuki; Kiyoshi Hasegawa; Kazushige Kiguchi; Bunpei Ishizuka
Journal:  Hum Cell       Date:  2007-11       Impact factor: 4.174

9.  Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome.

Authors:  Sashwati Roy; Savita Khanna; Cameron Rink; Sabyasachi Biswas; Chandan K Sen
Journal:  Physiol Genomics       Date:  2008-05-06       Impact factor: 3.107

10.  Investigations into specificity of azepinomycin for inhibition of guanase: discrimination between the natural heterocyclic inhibitor and its synthetic nucleoside analogues.

Authors:  Saibal Chakraborty; Niti H Shah; James C Fishbein; Ramachandra S Hosmane
Journal:  Bioorg Med Chem Lett       Date:  2012-10-02       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.